CCBIO PhD candidates
PhD Candidate Ehsan Hajjar
MS in medical cell biology from the University of Bergen and has been a PhD candidate in the Gjertsen group since 2015.
Main content
His project focuses on the modulation and function of p53 protein isoforms in acute myeloid leukemia. He is also examining the modulation of p53 protein isoforms in the leukemic cells treated by the AXL kinase inhibitor agent bemcentinib (BGB324).
Contact info to Ehsan Hajjar.
Read about the Gjertsen group.
30.10.2020